Regulation 3
Amendment of regulation 13
of Medi Shield Life Scheme(Amendment) Regulations 2026
In the principal Regulations, in regulation 13 —
in paragraph (2), replace “(2A)” with “(3A)”;
in paragraph (2), replace “each approved outpatient treatment,” with “each approved outpatient treatment received before 1 June 2026,”;
delete paragraph (2A);
in paragraph (3), replace “(4A) and (7)” with “(3A), (4A), (7) and (7B)”;
in paragraph (3), replace “claimable medical treatment or services received from an approved medical institution as an in‑patient, under the MIC@Home programme, or as day surgical treatment” with “specified claimable medical treatment or services”;
after paragraph (3), insert —“(3A) Any claim for repetitive transcranial magnetic stimulation treatment is subject to the following conditions:
an insured person is only entitled to claim for 2 courses of repetitive transcranial magnetic stimulation treatment in the insured person’s lifetime;
an insured person is only entitled to claim up to the following number of treatment sessions of repetitive transcranial magnetic stimulation for the first course of treatment:
where the insured person has received 24 or more treatment sessions for the first course of treatment before 1 June 2026 — 24 treatment sessions;
where the insured person has not received more than 23 treatment sessions for the first course of treatment before 1 June 2026 — 30 treatment sessions;
an insured person is only entitled to claim for a second course of repetitive transcranial magnetic stimulation treatment if the second course of treatment starts at least 120 days after the last treatment session of the first course of treatment;
an insured person is only entitled to claim up to the following number of treatment sessions of repetitive transcranial magnetic stimulation for the second course of treatment:
where the claim is made before 1 June 2026 — 15 treatment sessions;
where the claim is made on or after 1 June 2026 — 30 treatment sessions.”;
in paragraph (4A), after “claim for the administration”, insert “, before 1 June 2026,”;
in paragraph (4A), after “received”, insert “, before 1 June 2026,”;
replace paragraph (7) with —“(7) In paragraph (3), “relevant amount”, in respect of approved medical treatment or services that is a specified claimable medical treatment or services, is the lower of the following amounts:
an amount determined in accordance with the formula T × P, where —
P is the following pro‑ration factor applicable to the insured person:
where the approved medical treatment or services are received by the insured person as an approved outpatient treatment — the pro‑ration factor specified in the Fourth Schedule applicable to the insured person in relation to the type of approved outpatient treatment received by the insured person;
where the approved medical treatment or services are received by the insured person as an in‑patient, under the MIC@Home programme, or as day surgical treatment — the pro‑ration factor specified in the Fifth Schedule applicable to the insured person in relation to the type of approved medical treatment or services received by the insured person; and
T is the total amount of the charges payable for the approved medical treatment or services received by the insured person;
the total of the assured amounts for such approved medical treatment or services.”;
in paragraphs (7A) and (7C), after “administration”, insert “, before 1 June 2026,”;
in paragraph (8), in the definition of “insured person’s contribution”, replace the full‑stop at the end with a semi‑colon; and
after the definition of “insured person’s contribution”, insert —“ “specified claimable medical treatment or services” means any claimable medical treatment or services received from an approved medical institution —
as an in-patient, under the MIC@Home programme, or as day surgical treatment; or
as an approved outpatient treatment, on or after 1 June 2026.”.